Preventing cervical cancer in East Africa through community health initiatives
Project 1: A Public Health Approach to Cervical Cancer Prevention in East Africa
This study is working to help women in East Africa, especially those with HIV, by making it easier for them to get tested for HPV and receive cervical cancer care, all while involving their communities to ensure the approach feels right for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10866367 on NIH RePORTER |
What this research studies
This research focuses on addressing the high rates of cervical cancer among women in East Africa, particularly those living with HIV. It employs a public health approach that includes community mobilization led by Village Health Teams, self-collection of vaginal specimens for HPV testing, and mobile treatment teams to provide necessary care. By increasing access to HPV vaccination and screening, the project aims to improve early detection and treatment of cervical cancer. The initiative is designed to be culturally acceptable and feasible within the communities it serves.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living in East Africa, particularly those at risk for cervical cancer and those living with HIV.
Not a fit: Patients outside of East Africa or those who do not have access to community health initiatives may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of cervical cancer among women in East Africa, improving health outcomes and saving lives.
How similar studies have performed: Other research has shown success with community-based health interventions in improving cancer screening and prevention, making this approach promising.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.